Dopavision presents new research at ARVO virtual conference

Dopavision is presenting its new research findings at the ARVO conference, which is held virtually this year. The ARVO conference is the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) and one of the largest research conferences in vision world-wide, gathering key opinion leaders and experts in ophthalmology and myopia from across the globe.

Dopavision will present results from its recent research conducted with academic partners about the mechanism of action and the effectiveness of the technology underlying its MyopiaX technology.

Our Partners

Dopavision is funded as part of the BMBF’s Industry-in-Clinic Platform Program (FKZ: 13GW0625)